- ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE
This study is looking at a medicine called dexlansoprazole for children aged 2 to 11 with 'erosive oesophagitis' (a sore gullet). It wants to see if the medicine helps heal the gullet and keep it healed, and if it's safe.
Poland - ongoing, recruitingTherapeutic exploratory (Phase II)
AN EXPLORATORY, MULTICENTER, RANDOMIZED,DOUBLE BLIND STUDY OF CLINICAL OUTCOMES,TOLERABILITY, AND SAFETY OF 2 DOSES OF ORAL PANTOPRAZOLE IN PEDIATRIC PARTICIPANTS AGED 1 TO 11 YEARS AND 12 TO 17 YEARS WHO REQUIRE MAINTENANCE THERAPY FOR HEALED EROSIVE ESOPHAGITIS
This study is testing a medication called pantoprazole in children aged 1 to 17. It aims to see if different doses can keep a healed food pipe (oesophagus) from getting sore again, specifically in children with a past condition called erosive oesophagitis.
Slovakia · Belgium